|Articles|January 31, 2014
University Systems Among Those Choosing Forte Research To Centrally Manage Research
Forte Research Systems announced that six leading clinical research institutions selected the company?s enterprise research system last year.
Advertisement
Forte Research Systems announced that six leading clinical research institutions—from university systems, hospitals and cancer groups--selected the company’s enterprise research system, last year. Forte also offers a specialized clinical trial management systems (CTMS).
The following organizations chose OnCore Enterprise Research system to centrally manage clinical research operations, with half implementing the system across multidisciplinary research groups:
The following organizations chose OnCore Enterprise Research system to centrally manage clinical research operations, with half implementing the system across multidisciplinary research groups:
- University of Colorado Denver
- University of Hawaii Cancer Center
- Baylor College of Medicine
- Hoosier Oncology Group
- Fox Chase Cancer Center
- Northside Hospital
Read the full release here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
2
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
3
Latest NIMBLE Study Results Highlight Progress in gMG Research
4
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
5